Insulin-like growth factor binding protein-related protein 1 (IGFBP- rP1) is a potential tumor suppressor protein for prostate cancer

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2370-2375

  Sprenger, Cynthia C ^a   Damon, Susan E ^b   Hwa, Vivian ^c   Rosenfeld, Ron G ^c   Plymate, Stephen R ^a,b,d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; SOMATOMEDIN BINDING PROTEIN 1;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL DIVISION; CELL SIZE; DNA, COMPLEMENTARY; GENES, TUMOR SUPPRESSOR; HUMANS; HYDROXYUREA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0033562985     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Peehl, D., Cohen, P., and Rosenfeld, R. The role of insulin-like growth factors in prostate biology. J. Androl., 17: 2-4, 1996.
2. Plymate, S., Ware, J., Tennant, M., Thrasher, J., Chatta, K., and Birnbaum, R. Transformation and immortalization of human prostate epithelial cells alters responsiveness to IGF(IGF)-I and IGF binding protein expression and secretion. J. Clin. Endocrinol. & Metab., 81: 3709-3716, 1996.
3. Tennant, M., Thrasher, J., Twomey, P., Drivdahl, R., Birnbaum, R., and Plymate, S. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J. Clin. Endocrinol. & Metab., 81: 3774-3782, 1996.
4. Tennant, M., Thrasher, J., Twomey, P., Birnbaum, R., and Plymate, S. Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J. Clin. Endocrinol. & Metab., 81: 3783-3792, 1996.
5. Tennant, M., Twomey, P., Thrasher, J., Birnbaum, R., and Plymate S. Comparison of insulin-like growth factor-binding protein-2 and -3 mRNA and protein in normal human prostate epithelium, prostate intraepithelial neoplasia, and malignant tissue. J. Clin. Endocrinol. & Metab., 81: 411-420, 1996.
6. Chan, J., Stampfer, M., Giovannucci, E., Gann, P., Ma, J., Wilkinson, P., Hennekens, C., and Pollak, M. Plasma insulin-like growth factor-I, and prostate cancer risk: a prospective study. Science (Washington DC), 279: 563-571, 1998.
7. Mantzoros, C., Tzonou, A., Signorello, L., Stampfer, M., Trichopoulos, D., and Adami, H-O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer, 76: 1115-1118, 1997.
8. Hwa, V., Tomasini-Sprenger, C., Bermejo, A., Rosenfeld, R., and Plymate, S. Insulin-like growth factor binding protein-rP1 expression and regulation in the human prostate. J. Clin. Endocrinol. & Metab., 83: 4355-4362, 1998.
9. Akaogi, K., Okabe, Y., Sato, J., Nagashima, Y., Yasumitsu, H., Suggahara, K., and Miyazaki, K. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary-like structures of cultured vascular endothelial cells. Proc. Natl. Acad. Sci. USA, 93: 8384-8389, 1996.
10. Kim, H-S., Nagalla, S., Oh, Y., Wilson, E., Roberts, C., and Rosenfeld, R. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. USA, 94: 12981-12986, 1997.
11. Oh, Y., Nagalla, S., Yamanaka, Y., Kim, H., Wilson, E., and Rosenfeld, R. Synthesis and characterization of insulin-like growth factor binding protein (IGFBP-7). J. Biol. Chem., 271: 30322-30325, 1996.
12. Baxter, R., Binoux, M., Clemmons, D., Conover, C., Drop, S., Holly, J., Mohan, S., Oh, Y., and Rosenfeld, R. Recommendation for nomenclature of the IGFBP superfamily. Endocrinology, 139: 4036, 1998.
13. Rosenfeld, R., and Oh, Y Editorial: the blind men and the elephant - a parable for the study of insulin-like growth factor binding proteins. Endocrinology, 139: 5-7, 1998.
14. Murphy, M., Pykett, M., Harnish, P., Zang, K., and George, D. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ., 4: 715-722, 1993.
15. Hwa, V., Oh, Y., and Rosenfeld, R. Insulin-like growth factor binding protein: a proposed superfamily. Acta Pediatr. Scand., 88: 37-45, 1999.
16. Swisshelm, K., Ryan, K., Tsuchiya, K., and Sager, R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci. USA, 92: 4472-4476, 1995.
17. Damon, S., Haugk, K., Swisshelm, K., and Quinn, L. Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis. Exp. Cell Res., 237: 192-195, 1997.
18. Akaogi, K., Okabe, Y., Funahashi, Y., Yoshotake, Y., Nishihawa, K., Yasumitsu, H., Umeda, M., and Miyazaki, K. Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. Biochem. Biophys. Res. Comm., 198: 1046-1053, 1994.
19. Akaogi, K., Sato, J., Okabe, Y., Sakamoto, Y., Yasumitsu, H., and Miyazaki, K. Synergistic growth stimulation of mouse fibroblasts by tumor derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ., 7: 1671-1677, 1996.
20. Kato, M., Sato, H., Tsukada, T., Ikawa, Y., Aizawa, S., and Nagayoshi, M. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells. Oncogene, 12: 1361-1364, 1996.
21. Oh, Y., Nagalla, R., Yamanaka, Y., Kim, H., Wilson, E., and Rosenfeld, R. Synthesis and characterization of insulin-like growth factor-binding protein IGFBP-7. J. Biol. Chem., 271: 30322-30325, 1996.
22. Yamauchi, T., Umeda, F., Masakado, M., Isaji, M., Mizushima, S., and Nawata, H. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem. J., 303: 591-598, 1994.
23. Burger, A., Zhang, X., Li, H., Ostrowski, J., Beatty, B., Venanzoni, M., Papas, T., and Seth, A. Down-regulation of T1A12/mac25, a novel IGFBP related gene, is associated with disease progression in breast carcinomas. Oncogene, 16: 2459-2467, 1998.
24. Wilson, E., Oh, Y., and Rosenfeld, R. Generation and characterization of an IGFBP-7 antibody: identification of 31 kD IGFBP-7 in human biological fluids and Hs578T breast cancer conditioned media. J. Clin. Endocrinol. & Metab., 82: 1301-1303, 1997.
25. Bae, V., Jackson-Cook, C., Brothman, A., Maygarden, S., and Ware, J., Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int. J. Cancer, 58: 721-729, 1994.
26. Jackson-Cook, C., Bae, V., Edelman, W., Brothman, A., and Ware, J. Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genet. Cytogenet., 87: 14-23, 1996.
27. Bae, V., Jackson-Cook, C., Maygarden, S., Chen, J., Plymate, S., and Ware, J. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate, 34: 275-282, 1998.
28. Birnbaum, R., Ware, J., and Plymate, S. Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J. Endocrinol., 141: 535-540, 1994.
29. Damon, S., Maddison, L., Ware, J., and Plymate, S. Over-expression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation. Endocrinology, 139: 3456-3464, 1998.
30. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
31. Saeed, B., Zhang, H., and Ng, S. Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media. Prostate, 31: 145-152, 1997.
32. Oh, Y., Muller, H., Paam, H., and Rosenfeld, R. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem., 268: 26045-26048, 1993.
33. Oh, Y., Muller, H., Ng, L., and Rosenfeld, R. Transforming growth factor beta induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor binding protein-3 action. J. Biol. Chem., 270: 13859-13592, 1995.
34. Valentinis, B., Bhala, A., DeAngelis, T., Baserga, R., and Cohen, P. The human insulin-like growth factor binding protein-3 inhibits the growth of fibroblasts with targeted disruption of the IGF-I receptor gene. Mol. Endocrinol., 9: 361-367, 1995.
35. Radulescu, R. Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem. Sci., 19: 278, 1994.
36. Jaques, G., Noll, K., Wegmann, B., Witten, S., Kogan, E., and Radulescu, R. T. Nuclear localization of insulin-like growth factor binding protein-3 in a lung cancer cell line. Endocrinology, 138: 1767-1770, 1997.
37. Akaogi, K., Sato, J., Okabe, Y., Sakqamoto, Y., Yasumitsu, H., and Miyazaki k, K. Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ., 7: 1671-1677, 1996.
38. Thomas, T., Wang, H., Niclasen, P., O'Bryan, M., Evan, L., Groome, N., Pedersen, J., and Risbridger, G. Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer. J. Clin. Endocrinol. & Metab., 82: 3851-3858, 1997.
39. Thomas, T., Chapman, S., Hong, W., Gurusingfhe, C., Mellor, S., Fletcher, R., Pedersen, J., and Risbridger, G. Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia. Prostate, 34: 34-43, 1998.
40. Zhang, Z., Zhao, Y., Batres, Y., Lin, M., and Ying, S. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCaP. Biochem. Biophys. Res. Commun., 234: 362-365, 1997.
41. Oh, Y., Wilson, E., Kim, H., Yang, D., Rutten, M., Graham, D., Deveney, C., Hwa, V., and Rosenfeld, R. Regulation and biological action of IGFBP-7 in human breast cancer cells. Endocrine Society 1997 Annual Meeting, Minneapolis, MN, abst. P2-267, p. 351, 1997.